[DOI] [PubMed] [Google Scholar] 44.Huhta JC, Linask K, Bailey L
NCL urges FDA and consumers to take action as GLP-1 shortage ends, but infodemic continues Media Contact: Lisa McDonald, Vice President of Communications, (202)-207-2829 May 22 Conclusion of Mass Compounded GLP-1s Should Bring Clarity but Confusion Reigns Washington, DC Despite the end of the GLP-1 shortage and May 22 FDA-issued deadline for companies to stop mass compounding of the products, the National Consumers League (NCL) is concerned that the epidemic of GLP-1 misinformation will continue to confuse consumers with fake products that can put their health at risk
Middelhoff M, Nienhser H, Valenti G, Maurer HC, Hayakawa Y, Takahashi R, et al
But if you do choose to increase your dose, and if youre tolerating the medication well, a typical Mounjaro timeline looks like this: Weeks 1-4: starting dose, 2.5mg Weeks 5-8: increase to 5mg dose (if tolerated well) Weeks 9-12: increase to 7.5mg dose, (if tolerated well) Weeks 13-16: increase to 10mg dose, (if tolerated well) Weeks 17-20: increase to 12.5mg dose, (if tolerated well) Week 21 onwards: Maintenance dose of 15mg Its important to note that your prescriber will only increase your dose if youre tolerating Mounjaro well
Some older adults may tolerate creatine safely, although fluid intake, kidney function, medications, and overall health should still be reviewed before supplementation
